FINWIRES · TerminalLIVE
FINWIRES

Argenx's Vyvgart Beat Impressive With Focus On Upcoming Myositis Data, RBC says

By

Argenx's (ARGX) Vyvgart posted a strong Q2 beat on organic demand in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, prefilled syringe uptake, and a label expansion, RBC Capital Markets said in a note emailed Friday.

The firm highlighted that most payers have dropped serology testing requirements ahead of treatment, potentially removing an adoption barrier, while Japan results included a one-time benefit tied to a wholesaler distribution change.

RBC said sequential growth topped prior-year trends, suggesting sales may be inflecting further ahead of a potential ocular myasthenia gravis label expansion.

RBC noted the pivotals for both myositis and multifocal motor neuropathy are on track to read out in the second half of the year.

RBC maintained its outperform rating and increased the price target to 1,025 from $945.

Price: $918.54, Change: $-6.06, Percent Change: -0.66%

Related Articles

Wire

Business First Bancshares Q2 Earnings, Revenue Rise; Shares Drop After Hours

Business First Bancshares (BFST) reported core Q2 earnings late Thursday of $0.71 per diluted share, up from $0.66 a year earlier.Analysts polled by FactSet expected $0.70.Revenue in the three months ended June 30, expressed as net interest income plus total other income, rose to $91.8 million from $81.5 million.Four analysts expected $91.3 million.The company's shares fell 3.3% in after-hours trading.

$BFST
Wire

RingCentral Q2 Adjusted Earnings, Revenue Rise; FY Guidance Increases

RingCentral (RNG) reported Q2 non-GAAP net income late Thursday of $1.22 per diluted share, up from $1.06 a year earlier.Analysts polled by FactSet expected $1.16.Revenue in the three months ended June 30 rose to $657 million from $620 million a year earlier.Analysts expected $650.5 million.RingCentral expects Q3 non-GAAP EPS of $1.25 to $1.30 on revenue of $664 million to $670 million.Analysts expect EPS of $1.25 on revenue of $663.2 million.The company raised full-year non-GAAP EPS guidance to the range of $4.96 to $5.10 on revenue of $2.635 billion to $2.646 billion. The previous forecast was EPS of $4.85 to $5.01 on revenue of $2.62 billion to $2.64 billion.Analysts expect EPS of $4.92 on revenue of $2.63 billion.RingCentral shares rose 1.2% in after-hours trading.

$RNG
Wire

Robert Half Q2 Net Income, Revenue Fall; Shares Drop After Hours

Robert Half (RHI) reported Q2 net income late Thursday of $0.26 per share, down from $0.41 a year earlier.Analysts polled by FactSet expected $0.26.Revenue in the three months ended June 30 fell to $1.34 billion from $1.37 billion a year earlier.Analysts expected $1.32 billion.The company's shares fell 5.3% in after-hours trading.

$RHI